SunTrust analyst Charles Brady lowered his price target on NN Inc to $16 after its Q4 earnings miss, also lowering his FY19 EPS outlook by 40c to $1.17. The analyst is keeping his Buy rating on the shares however, stating that while a "meaningful improvement is still 1-2 quarters away" following a disappointing 2018 performance, he believes that that NN's current price "significantly undervalues the company." Brady is positive on the company's organic growth in Life Sciences business, even though its Mobile Solutions segment remains constrained by the global auto weakness and its Power Solutions business underperformed.